Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study
NCT ID: NCT04384614
Last Updated: 2020-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2020-05-15
2020-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
I VACCIN Hospitalization of COVID-19 Patients
NCT05244343
Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana
NCT02281643
Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.
NCT04362124
The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes
NCT04832932
Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19
NCT04350931
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID (+)
Patients COVID19(+) confirmed by PCR
Test PCR
Viral load (COVID+) testing by PCR
TDR
IDR and blood sampling for testing DNA Cheque
Clinical Examination
COVID 19 symptoms and Physical Examination
COVID (-)
Patients COVID19 (-) who had been in contact with COVID-19 (+) confirmed by PCR
Test PCR
Viral load (COVID+) testing by PCR
TDR
IDR and blood sampling for testing DNA Cheque
Clinical Examination
COVID 19 symptoms and Physical Examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test PCR
Viral load (COVID+) testing by PCR
TDR
IDR and blood sampling for testing DNA Cheque
Clinical Examination
COVID 19 symptoms and Physical Examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COVID-19 (-) confirmed by PCR test having been in contact with COVID-19 (+)
Exclusion Criteria
* COVID-19 (-) Not having been in contact with COVID19(+)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eshmoun Clinical Research Center
NETWORK
Dacima Consulting
OTHER
Direction des Soins de Santé de Base
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Agnès Hamzaoui
Head of department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Agnès Hamzaoui, Pr
Role: PRINCIPAL_INVESTIGATOR
Hopital Abderrahmane Mami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eshmoun Clinical Research Centre
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECC2020-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.